Affiliated

Affiliated Dermatologists & Dermatologic Surgeons Partners with Epiphany Dermatology

Epiphany Dermatology Expands into New Jersey Through Strategic Partnership with Affiliated Dermatologists & Dermatologic Surgeons Epiphany Dermatology, a prominent and rapidly growing dermatology platform dedicated to enhancing access to high-quality skin care, has announced its entry into the New Jersey…

Read MoreAffiliated Dermatologists & Dermatologic Surgeons Partners with Epiphany Dermatology
Sesh

Sesh Products US Nicotine Pouch Bundled PMTA Progresses FDA Substantive Scientific Review Stage

FDA Accepts Application Covering 64 SKUs, Moving Sesh Closer to Potential Marketing Authorization Sesh Products US, Inc. has announced a significant regulatory milestone in its efforts to bring its nicotine pouch products to the U.S. market. The company confirmed that…

Read MoreSesh Products US Nicotine Pouch Bundled PMTA Progresses FDA Substantive Scientific Review Stage
Gilead

Gilead Sciences Expands Autoimmune Pipeline with Acquisition of Ouro Medicines

Gilead Sciences Moves to Acquire Ouro Medicines, Strengthening Its Autoimmune and Inflammation Pipeline with Innovative T-Cell Engager Technology Gilead Sciences has announced a major strategic step to expand its presence in the autoimmune disease space through a definitive agreement to…

Read MoreGilead Sciences Expands Autoimmune Pipeline with Acquisition of Ouro Medicines
Bristol

Bristol Myers Squibb Advances Hodgkin Lymphoma Care Expanded Opdivo Approvals

Bristol Myers Squibb gains U.S. Food and Drug Administration and European Medicines Agency approvals, expanding Opdivo use in Hodgkin lymphoma Bristol Myers Squibb has announced significant regulatory milestones that mark a major advancement in the treatment landscape for classical Hodgkin…

Read MoreBristol Myers Squibb Advances Hodgkin Lymphoma Care Expanded Opdivo Approvals
Curi

Curi Bio & Battelle Partner to Advance Neuromuscular Drug Testing

Strategic Collaboration to Accelerate Human-Relevant Neuromuscular Testing Curi Bio and Battelle have announced a strategic collaboration aimed at transforming the field of neuromuscular pharmacology through the accelerated adoption of New Approach Methods (NAMs). This partnership represents a significant step forward…

Read MoreCuri Bio & Battelle Partner to Advance Neuromuscular Drug Testing
Aptars

Aptar’s Unidose Nasal Powder System Featured in Phase II Study of ENA’s INNA-051 Nasal Spray

Aptar’s Introduction to INNA-051 Investigational Nasal Spray AptarGroup a global leader in drug delivery, dosing, and protection technologies, has announced the use of its Unidose (UDS) Powder Nasal Spray System in a Phase II clinical study being conducted by ENA…

Read MoreAptar’s Unidose Nasal Powder System Featured in Phase II Study of ENA’s INNA-051 Nasal Spray